S100A1 and metabolic dysfunction-associated steatotic liver disease: Coarse analyses of hepatic tissues in humans and various animal models performed so far clearly indicate significant alterations of several S100 isoforms at different stages of NAFLD/NASH and in HCC (Figure 6 and [65]).